Symbols / APLS $40.89 -0.12% Apellis Pharmaceuticals, Inc.

Healthcare • Biotechnology • United States • NMS
APLS Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 5.23B Enterprise Value 5.24B Income 22.39M Sales 1.00B Book/sh 2.92 Cash/sh 3.66
Dividend Yield Payout 0.00% Employees 733 IPO P/E 227.17 Forward P/E -167.41
PEG P/S 5.21 P/B 13.99 P/C EV/EBITDA 91.95 EV/Sales 5.22
Quick Ratio 2.59 Current Ratio 3.14 Debt/Eq 128.15 LT Debt/Eq EPS (ttm) 0.18 EPS next Y -0.24
EPS Growth Revenue Growth -5.90% Earnings 2026-05-07 ROA 3.53% ROE 7.48% ROIC
Gross Margin 60.34% Oper. Margin -25.58% Profit Margin 2.23% Shs Outstand 127.84M Shs Float 83.30M Short Float 25.78%
Short Ratio 3.98 Short Interest 52W High 40.95 52W Low 16.10 Beta -0.20 Avg Volume 5.18M
Volume 2.13M Target Price $40.93 Recom Hold Prev Close $40.94 Price $40.89 Change -0.12%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
Latest analyst target
3. DCF / Fair value
$-2.18
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
Low
High
Mean

No recent news from Yahoo. Try the RSS feed for latest APLS news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-17 SULLIVAN TIMOTHY EUGENE Chief Financial Officer 11,096 $0.00 $0
2026-03-11 FRANCOIS CEDRIC Chief Executive Officer 64,869 $0.00 $0
2026-02-27 DOLSTEN MIKAEL G Director 14,312 $0.00 $0
2026-02-11 DELONG MARK JEFFREY Officer 368 $22.15 $8,153
2026-02-03 FRANCOIS CEDRIC Chief Executive Officer 8,840 $3.76 $33,238
2026-01-28 FRANCOIS CEDRIC Chief Executive Officer 195,952 $0.00 $0
2026-01-28 WATSON DAVID OSBORNE General Counsel 55,986 $0.00 $0
2026-01-28 DESCHATELETS PASCAL Officer 25,840 $0.00 $0
2026-01-28 NICHOLSON NUR Chief Technology Officer 45,220 $0.00 $0
2026-01-28 CHOPAS JAMES GEORGE Officer 16,150 $0.00 $0
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category